Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
This Bitcoin-focused microcap is building a treasury strategy centered on accumulating BTC (click to learn more) Laser Photonics Reports Full Year Total Net Sales Increase of 144% in Q4 2025 Financial Results (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Cytophage Technologies Ltd V.CYTO

Alternate Symbol(s):  CPTCF

Healthcare Biotechnology
Cytophage Technologies Ltd., a biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada. It develops poultry health products under the AviPhage name; food safety products under the PhageFend name; bovine mastitis products under the BoviPhage name... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (TSXV:CYTO)

Cytophage Announces Departure of Chief Operating Officer

TheNewsWire 6 days ago

Cytophage Announces Formation of Special Committee of Independent Directors to Evaluate Strategic Alternatives

TheNewsWire March 6, 2026

Canadian Investment Regulatory Organization Trade Resumption - CYTO

Canada NewsWire February 19, 2026

Canadian Investment Regulatory Organization Trading Halt - CYTO

Canada NewsWire February 19, 2026

Cytophage Announces Operational Restructuring

TheNewsWire February 19, 2026

Cytophage Announces Appointment of James Kinley as Chief Financial Officer

TheNewsWire January 20, 2026

Cytophage Announces Closing of Non-Brokered Private Placement and Filing of Q3 Financials

TheNewsWire November 28, 2025

Cytophage Announces Closing of First Tranche of Non-Brokered Private Placement

TheNewsWire November 12, 2025

Cytophage Announces Closing Date of its Non-Brokered Private Placement

TheNewsWire November 5, 2025
View More News ››

Opinion & Analysis (TSXV:CYTO)

No current opinion is available.
View More Opinion ››

Bullboard Posts (TSXV:CYTO)

unsolicited strategic financing proposals

  Winnipeg – March 6, 2026– TheNewswire — Cytophage Technologies Ltd. (“Cytophage” or the “Company”) (TSXV: CYTO; FSE: 70G...
JimMc10 - March 20, 2026

$800k in 3 salaries while losing money hand over fist. POS..

$800k in 3 salaries while losing money hand over fist. POS..
RadicalRoad3 - January 2, 2026

RE:Commercialization of OvaPhage in Canada

<< View Post To Watch Video >>
JimMc10 - November 3, 2025

Commercialization of OvaPhage in Canada

https://www.thenewswire.com/press-releases/1LpMFgyV9-cytophage-announces-the-commercialization-of-ovaphage-in-canada-through-w-l-t...
lscfa - October 16, 2025

Spend spend spend

Absolute POS
RadicalRoad3 - September 26, 2025

Successful study results

https://www.thenewswire.com/press-releases/1k1vFlRRb-cytophage-reports-successful-results-and-data-from-second-eu-pilot-study-for...
lscfa - September 24, 2025
View more Bullboard ››

Diagnostear Technologies Inc

Diagnostear Technologies Inc

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic ...
View More »

Podcasts